Boron detection from blood samples by ICP-AES and ICP-MS during boron neutron capture therapy

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 68, Issue 8, 2008, Pages 696-702

  Linko, S ^a,e   Revitzer, H ^b   Zilliacus, R ^c   Kortesniemi, M ^d,e   Kouri, M ^a,e   Savolainen, S ^d,e  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b AALTO UNIVERSITY   (Finland)

^c VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e Boneca Corporation   (Finland)

Author keywords

Boron neutron capture therapy; Cancer of head and neck; Inductively coupled plasma atomic emission spectrometry; Inductively coupled plasma mass spectrometry; Radiation oncology

Indexed keywords

BORON 10;

ARTICLE; ATOMIC EMISSION SPECTROMETRY; BLOOD SAMPLING; CONTROLLED STUDY; DIRECT CURRENT; HUMAN; MASS SPECTROMETRY; NEUTRON CAPTURE THERAPY; PRIORITY JOURNAL;

BORON; BORON NEUTRON CAPTURE THERAPY; HUMANS; MASS SPECTROMETRY; SPECTROPHOTOMETRY, ATOMIC;

EID: 57349083285     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510802100831     Document Type: Article

References (19)

1. Barth RF, Soloway AH, Fairchild RG, Brugger RM. Boron neutron capture therapy for cancer. Realities and prospects. Cancer 1992;70:2995-3007.
2. Coderre JA, Morris GM. The radiation biology of boron neutron capture therapy. Radiat Res 1999;151:1-18.
3. Kortesniemi M, Seppala T, Auterinen I, Savolainen S. Enhanced blood boron concentration estimation for BPA-F mediated BNCT. Appl Radiat Isot 2004;61:823-7.
4. 10B in blood after BPA-fructose complex infusion. Phys Med Biol 2002;47:737-45.
5. Ryynänen P, Kortesniemi M, Coderre J, Diaz A, Hiismäki P, Savolainen S. Models for estimation of the 10B concentration after BPA-fructose complex infusion in patients during epithermal neutron irradiation in BNCT. Int J Radiat Oncol Biol Phys 2000;48:1145-54.
6. Auterinen I, Hiismäki P, Kotiluoto P, Rosenberg RJ, Salmenhaara S, Seppälä T, et al. Metamorphosis of a 35 years old TRIGA reactor into a modern BNCT facility. In: Hawthorne MF, Shelly K, Wiersema RJ, editors. Frontiers in neutron capture therapy. New York: Plenum. p. 267-75.
7. Joensuu H, Kankaanranta L, Seppala T, Auterinen I, Kallio M, Kulvik M, et al. Boron neutron capture therapy of brain tumors: clinical trials at the Finnish facility using boron phenylalanine. J Neurooncol 2003;62:123-34.
8. Kouri M, Kankaanranta L, Seppala T, Tervo L, Rasilainen M, Minn H, et al. Undifferentiated sinonasal carcinoma may respond to single-fraction boron neutron capture therapy. Radiother Oncol 2004;72:83-5.
9. NIH Clinical Trials. Available at: www.clinicaltrials.gov.
10. Kankaanranta L, Seppala T, Koivunoro H, Saarilahti K, Atula T, Collan J, et al. Boron neutron capture therapy in the treatment of locally recurred head and neck cancer. Int J Radiat Oncol Biol Phys 2007;69:475-82.
11. Laakso J, Kulvik M, Ruokonen I, Vahatalo J, Zilliacus R, Farkkila M, et al. Atomic emission method for total boron in blood during neutron-capture therapy. Clin Chem 2001;47:1796-803.
12. Bauer WF, Micca PL, White BM. A rapid method for the direct analysis of boron in whole blood by atomic emission spectroscopy. In: Soloway AH, Barth RF, Carpenter DE, editors. Advances in neutron capture therapy. New York: Plenum Press.
13. Nichols TL, Kabalka GW, Miller LF, Khan MK, Smith GT. Improved treatment planning for boron neutron capture therapy for glioblastoma multiforme using fluorine-18 labeled boronophenylalanine and positron emission tomography. Med Phys 2002;29:2351-8.
14. Imahori Y, Ueda S, Ohmori Y, Sakae K, Kusuki T, Kobayashi T, et al. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part II. Clin Cancer Res 1998;4:1833-41.
15. Zuo CS, Prasad PV, Busse P, Tang L, Zamenhof RG. Proton nuclear magnetic resonance measurement of p-boronophenylalanine (BPA): a therapeutic agent for boron neutron capture. Med Phys 1999;26:1230-6.
16. 10B-carrier, BPA-F: phantom studies at 1.5 and 3.0 T. Phys Med Bio 2003;48:1027-39.
17. 10B-carrier, BPA-F using STEAM and PRESS MRS sequences: detection limit and quantification Spectrosc. Int J 2004;18:133-42.
18. 10B-carrier, L- p-boronophenylalanine-fructose. EJR 2005;56:154-9.
19. Munck af Rosenschold PM, Verbakel WF, Ceberg CP, Stecher-Rasmussen F, Persson BR. Toward clinical application of prompt gamma spectroscopy for in vivo monitoring of boron uptake in boron neutron capture therapy. Med Phys 2001;28:787-95.